Skip to content
Advertisement
Author profile
Sean Salai

Sean Salai

ssalai@washingtontimes.com

Sean Salai is the general assignment/culture reporter for The Washington Times. A former National desk intern and Metro clerk at The Washington Times, he also has served as a City Hall reporter at the Boca Raton News and as a special contributor at America Media. He can be reached at ssalai@washingtontimes.com.

Articles by Sean Salai

In this Tuesday, May 19, 2020, photo, health investigator Mackenzie Bray adjusts her mask at the Salt Lake County Health Department, in Salt Lake City. Bray normally works to track contacts for people with sexually transmitted diseases, but she was re-assigned during the coronavirus pandemic. She is now one of 130 people at this county health department assigned to track down COVID-19 cases in Utah's urban center around Salt Lake City. The investigators, many of them nurses, each juggle 30 to 40 cases that can include a total of several hundred people. (AP Photo/Rick Bowmer) **FILE**

CDC: Gonorrhea, syphilis rose during first year of pandemic

Cases of the sexually transmitted diseases gonorrhea and syphilis increased during the first year of the COVID-19 pandemic, with more than half of the infections coming from young people aged 15-24, the Centers for Disease Control and Prevention reported.

April 15, 2022
Oklahoma Gov. Kevin Stitt poses for a photo with the bill he signed, making it a felony to perform an abortion, punishable by up to 10 years in prison, Tuesday, April 12, 2022, in Oklahoma City, following a bill signing ceremony. (AP Photo/Sue Ogrocki)

Abortion rights without Roe poised to splinter across states, jurisdictions, courts

Performing an abortion in Oklahoma will be a felony punishable by up to 10 years in prison under a bill signed into law by Gov. Kevin Stitt on Tuesday -- just three days after lawmakers in Maryland went the other direction, expanding not only who can perform abortions but requiring insurance to cover the procedure at no cost to the policyholder.

April 12, 2022
The Biogen Inc., headquarters, Wednesday, March 11, 2020, in Cambridge, Mass. Medicare says it’s considering a cut in enrollee premiums, after officials stuck with an earlier decision to sharply limit coverage for a pricey new Alzheimer’s drug projected to drive up program costs.  (AP Photo/Steven Senne) **FILE**

Medicare limits coverage of new Alzheimer’s treatment

Officials at the U.S. Department of Health and Human Services will restrict Medicare coverage of a new Alzheimer's treatment to clinical trials, rejecting activists who had demanded full access for early-onset dementia patients.

April 11, 2022